Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Yunkang Group Limited ( (HK:2325) ) has provided an update.
Yunkang Group Limited has entered into a new three-year property lease agreement under which its subsidiary Guangzhou Daan will lease around 10,468 sq m of premises in Guangzhou’s Science City from controlling shareholder Da An Gene, along with related services such as water and electricity supply, from 1 January 2026 to 31 December 2028. The arrangement, treated as an acquisition of a right-of-use asset of about RMB9.5 million under IFRS 16 and as continuing connected transactions for service fees, falls within thresholds that require reporting and public announcement but are exempt from independent shareholders’ approval, ensuring continuity of facilities for the group while maintaining compliance with Hong Kong connected-transaction rules.
The most recent analyst rating on (HK:2325) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Yunkang Group Limited stock, see the HK:2325 Stock Forecast page.
More about Yunkang Group Limited
Yunkang Group Limited is a healthcare-focused company listed in Hong Kong that operates through subsidiaries such as Guangzhou Daan, with activities linked to medical and scientific facilities in Guangzhou’s High-tech Industry Development Zone. Its operations involve the use of specialised premises and infrastructure suitable for laboratory, diagnostic or related health-industry services.
Average Trading Volume: 1,339,906
Technical Sentiment Signal: Sell
Current Market Cap: HK$633.7M
For a thorough assessment of 2325 stock, go to TipRanks’ Stock Analysis page.